🔓
Sign in as a Member to unlock the full view of HR.10336. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
HR.10336 · 119TH CONGRESS

To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.

Status
In Committee
Latest Action
2026-09-10
Sponsor
Harshbarger, Diana (R-Tennessee)
Official Source
Congress.gov
Investability
0/100
Stage
COMMITTEE
Related Bills
0
Full Text
Unavailable
Alive
Yes

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Frequently Asked Questions

Did HR.10336 pass?
HR.10336 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HR.10336?
HR.10336 was sponsored by Diana Harshbarger (R-Tennessee).

Full Bill Text

⚖️ View on Congress.gov 📄 PDF (GovInfo) 🔗 Copy link
Full text not yet indexed for this bill. Check Congress.gov for the official text.
🔒 GovGreed Pro · Trading Intelligence on HR.10336 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-09-14. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]